Literature DB >> 11839889

Innovative endovascular defibrillator lead use in superior vena cava obstruction.

Tomasz Stys1, Shalini Kapoor, Danielle Carter-Adkins, Roman T Pachulski.   

Abstract

BACKGROUND: We describe an unusual case of severe heart failure (HF) and rapid atrial fibrillation (AF) improved through ablation and pacemaker implant despite superior vena cava obstruction (SVCO).
METHODS: SVCO precluded upper body venous access to the heart for procedural rate control. Both AV Junctional ablation and permanent endovascular lead placement were achieved through the inferior vena cava (IVC).
RESULTS: Clinical improvement from NYHA Class IV to Class II HF was observed with effective nonpharmacologic ventricular rate control.
CONCLUSIONS: HF patients with rapid AF and SVCO can achieve ventricular rate control through lower body venous access to the heart utilizing 100-cm endovascular defibrillator rate sensing leads.

Entities:  

Mesh:

Year:  2002        PMID: 11839889     DOI: 10.1023/a:1014136509320

Source DB:  PubMed          Journal:  J Interv Card Electrophysiol        ISSN: 1383-875X            Impact factor:   1.900


  6 in total

1.  Rationale and design of a randomized clinical trial to assess the safety and efficacy of cardiac resynchronization therapy in patients with advanced heart failure: the Multicenter InSync Randomized Clinical Evaluation (MIRACLE).

Authors:  W T Abraham
Journal:  J Card Fail       Date:  2000-12       Impact factor: 5.712

2.  Iliac vein approach to permanent pacemaker implantation.

Authors:  M H Ellestad; J French
Journal:  Pacing Clin Electrophysiol       Date:  1989-07       Impact factor: 1.976

3.  Permanent ventricular pacing: a ten year experience. Complications of implantation, incidence of congestive heart failure and coronary artery disease.

Authors:  M A Codini; D G Caralis; G C Voigt
Journal:  Johns Hopkins Med J       Date:  1974-02

4.  The North American experience with the Ablate and Pace Trial (APT) for medically refractory atrial fibrillation.

Authors:  M A Wood; G N Kay; K A Ellenbogen
Journal:  Europace       Date:  1999-01       Impact factor: 5.214

5.  Four hundred consecutive patients with permanent transvenous pacemakers.

Authors:  E F Conklin; S Giannelli; T F Nealon
Journal:  J Thorac Cardiovasc Surg       Date:  1975-01       Impact factor: 5.209

6.  Congenital absence of superior vena cava: unusual anomaly of superior systemic veins complicating pacemaker placement.

Authors:  S A Hussain; S Chakravarty; A Chaikhouni; J R Smith
Journal:  Pacing Clin Electrophysiol       Date:  1981-05       Impact factor: 1.976

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.